During the past decade, Bronx Lebanon Hosp Ctr conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 19 clinical trials were completed, i.e. on average, 190% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bronx Lebanon Hosp Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 74 trials, followed by "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 7 trials sponsored, "AIDS Clinical Trials Group" with 5 trials sponsored, "Bronx-Lebanon Hospital Center Health Care System" with 4 trials sponsored and "Harvard School of Public Health (HSPH)" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bronx Lebanon Hosp Ctr" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 34 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 19 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 11 trials as a collaborator, "Glaxo Wellcome" with 8 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Bronx Lebanon Hosp Ctr" are "HIV Infections" (86 trials), "Pregnancy" (5 trials), "Tuberculosis" (5 trials), "Pneumonia, Pneumocystis Carinii" (4 trials) and "HIV Infection" (3 trials). Many other conditions were trialed in "Bronx Lebanon Hosp Ctr" in a lesser frequency.

Most popular intervention types in "Bronx Lebanon Hosp Ctr" are "Drug" (74 trials), "Biological" (11 trials), "Behavioral" (8 trials), "Other" (7 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (16 trials), "Didanosine" (11 trials), "Lamivudine" (8 trials), "Ritonavir" (8 trials) and "Stavudine" (8 trials). Other intervention names were less common.

The vast majority of trials in "Bronx Lebanon Hosp Ctr" are 110 trials for "All" genders and 14 trials for "Female" genders.

Currently, there are NaN active trials in "Bronx Lebanon Hosp Ctr". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Bronx Lebanon Hosp Ctr, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bronx Lebanon Hosp Ctr, 17 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 26 trials that are defined as “Not Applicable".

Bronx Lebanon Hosp Ctr has several departments that took part in Clinical trials: "Bronx Lebanon Hosp Ctr / Dept of Pediatrics" - 2 trials